AI for Health

✨(Re)live the 7th edition of the AI for Health Summit - Official Aftermovie ✨ On November 21st, over 2000 of you attended the AI for Health 2024 Summit, co-founded with Artefact & Johnson & Johnson. A huge thank you to our 145+ speakers, 39 exhibitors, and 200+ startups who made this event such a success. Your energy, insights, and enthusiasm truly brought the AI for Health 2024 Summit to life! We’re excited to announce that AI for Health will return on November 25th and 26th, 2025 at the iconic Grand Palais - RMN (Officiel) in Paris. Get ready for an even bigger and bolder celebration of innovation for health! A special shoutout to our partners, exhibitors, and speakers for their presence and inspiring contributions 👏(Re)discover our ecosystem members here: 🩺 From the pharmaceutical and healthcare industry: Johnson & Johnson Innovative Medicine France, Amgen, Biogen, Clariane, Novo Nordisk, Pfizer, Servier, Takeda. 🏛️ From institutions: ANAP, Aspire, Centre Léon Bérard, EIT Health, Ministère de la Santé, Caisse nationale de l’Assurance Maladie, Healthcare Data Institute, Agence de l'innovation en santé, Inria, Institut Curie, IUCT-Oncopole (Institut Universitaire du Cancer de Toulouse), numeum, PariSanté Campus, Resah, Unicancer. 🔧 From the tech ecosystem: Amazon Web Services (AWS), InstaDeep, IQVIA France, Microsoft, MyData-TRUST, Nebius, Pure Storage, Salesforce, Sqilline Health, Theodo HealthTech (ex-Hokla), TriNetX, VIDAL. 🚀 From the startup and scale-up ecosystem: ADLIN Science, B Consultant, Biolevate, CODOC, Deemea, DrData, Doctolib, Emerit Science, ErVimmune, GENerX Life, Kustoma, My S Life, Numind, Octopize, O-KIDIA, Opscidia, Praxy.ai, Pulselife, Qalita, Radiologs, Second Brain, Skezi, Sparta Care, Synapse Medicine, Tandem Health, Team HART, TraceX, Trustii.io, Use & Share, Whitelab Genomics. To watch the aftermovie, check it out here: https://lnkd.in/etctDGHu See you next year! 💡

🔬 #2 Discover our insights for supporting the use of AI in clinical trials in France! (In French) At the AI for Health 2024 Summit, we convened experts to explore how France can lead the way in integrating AI into clinical trials. This white paper captures the key insights shared during our second workshop. 🔍 Workshop goals: > Examine the current landscape of clinical trials in France and highlight recent developments. > Identity some of the key challenges and address those with a potential set of actionable solutions. > Share insights on how AI can enhance the processes of clinical trials, featuring 3 use cases. 💡Keywords of potential solutions (detailed in the white paper): > Data quality > Incentive development framework > Awareness-raising among healthcare professionals and researchers > Patient involvement > Validation framework for AI methods > Ecosystem collaboration 📊 3 Use cases discussed: 🔹 Clinical Trial Simulation Platform 🔹 Patient Stratification 🔹 Augmented Cohorts 🇫🇷France’s potential : With its diverse assets, France has the necessary advantages to become a global leader in the integration of AI into clinical trials. By addressing the identified challenges and mobilising its resources, it could strengthen its role in advancing new and better therapeutic treatments for patients. 🙏 We extend our heartfelt thanks to the workshop participants, for their time, expertise and corrections on our different versions: Stéphanie Allassonniere (Université Paris Cité), Marguerite BRAC DE LA PERRIERE (Fieldfisher), Thibault Chesnel (IQVIA France), Manon de FALLOIS (CNIL), Marine Delahay Lalin (Johnson & Johnson Innovative Medicine France), Jérôme Fabiano (EIT Health), Clotilde Genon (ELLyE - Ensemble Leucémie Lymphomes Espoir), Stephanie Kervestin - Yates (ariis - Alliance Recherche Innovation Industries Santé), Cinira Leal-Lefèvre (Takeda), Hervé Nabarette, AFM Téléthon and Emmanuel P. (Nova In Silico). We can’t wait for the next AI for Health Summit and the follow-up of these discussions! This work is only a glance at all the work and potential yet to come ✍️ Nota bene:  This white paper does not commit the institutions to which the contributors participating in this workshop are affiliated. This white paper reflects the thoughts and discussions from a two-hour workshop, which naturally limits the depth and level of technical detail addressed. #AI #ClinicalTrials #AIForHealth

Let’s talk about AI & Women’s Health! 🌟 AI for Health is proud to partner with Femtech France for a special evening dedicated to AI & Women's Health, taking place on February 10 in Paris, alongside the Elysée #AIActionSummit. 💡 What’s on the agenda? 🔹 Debate "AI in women's health: threat or opportunity?" 🔹 Ask Me Anything session with three leading French femtech startups 🔹 Global insights on AI innovations in women’s health 🔹 Networking cocktail to connect with industry leaders 🔗 Join us & get 20% off your ticket with this exclusive link:  https://lnkd.in/dKdpkXUS Let’s shape the future of AI-driven women’s health together! 💙 ✨ #AIforHealth #Femtech #WomensHealth #ArtificialIntelligence #HealthTech

See you tomorrow at Le Grand Rex ! 🎥 Experience Vision will showcase how immersive experiences and AI applications transform different industries 🎤⚕️Meet us at 11:30 on the Healthcare stage with Yann-Mael Le Douarin from Direction générale de l'offre de soins (DGOS) to talk about AI & VR use cases towards an inclusion in a national strategy I’ll be representing AI for Health by Artefact and explain the importance of ecosystemic and holistic approaches to help connect use cases, innovators and deciders towards a value-based strategy Looking forward to connecting with inspiring speakers and all the ecosystem in this iconic Parisian venue ✨ Kudos to Othman Chiheb 🌟 and team!

▶ Ready to Explore the Future of Drug Discovery? Watch the Replay now! On November 21st, the AI for Health Summit 2024 at STATION F hosted the session "The Generative AI Revolution for Drug Discovery: a State of the Art." We reunited experts to explore the transformative potential of AI in drug discovery: 👉 Alex Merwin, Head of Growth, Healthcare & Life Sciences Startups at Amazon Web Services (AWS) 👉 Yann Gaston-Mathe, CEO & Founder of iktos 👉 Samantha J., Partner at Elaia 👉 Hervé Minoux, Head of AI for Large Molecule Research at Sanofi 🎤 Moderated by Sandrine Cochard, Editorial Director at the Mind Group MindHealth 💡 Key takeaways from the session: 1️⃣ Generative AI in drug discovery: Generative AI is transforming drug development by navigating vast chemical spaces and optimizing molecule design. Large language models and advanced AI tools are being adapted to generate viable drugs, accelerating the R&D process and significantly reducing timelines. 2️⃣ Strategic collaborations: Leading pharmaceutical companies, such as Sanofi with OpenAI and Formation Bio, are partnering with AI startups to leverage cutting-edge technologies. These collaborations are revolutionizing the drug discovery process and integrating AI solutions to tackle complex challenges in the pharmaceutical industry. 3️⃣ AI-driven ecosystem development: The growing ecosystem of AI-powered startups is supported by platforms and investors. These connections between early-stage innovations and large-scale applications in biotherapeutics and health tech are accelerating advancements in drug discovery and health solutions. 🚀 What are your thoughts on the future of AI in drug discovery? Share your insights and join the conversation! Catch the full session replay here! 👇 https://lnkd.in/e-4jBwC8 A big thank you to all our speakers, and we are looking forward to seeing you at the Grand Palais - RMN (Officiel) in 2025! #AIforHealth #GenerativeAI #DrugDiscovery

🎥🚀 Discover AI's Impact on Healthcare - Replay Available Now! On November 21st, the AI for Health Summit 2024 at STATION F hosted the masterclass "Evaluation of AI technologies & EU HTA: Towards European Standards?" A big thank you to our speakers: 🔹 Randi Laukli, Director of Communications at Norwegian Centre for E-health Research 🔹 Rossella Di Bidino, HTA and AI expert at  EDITHA 🔹 Dr. Dr. Derya Şahin, Policy Analyst - Data, AI & Health at OECD.AI 🔹 Charlotte Barot, AI Analyst at CNIL And to our moderator, Jérôme Fabiano, Deputy Managing Director from our ecosystem member EIT Health France, for guiding the discussion. We explored the challenges and opportunities surrounding AI in healthcare. Here are the key takeaways: 🔍 Regulatory challenges of AI: Managing AI-related risks is complex, with a key focus on aligning data protection regulations (GDPR) with the AI Act, which imposes stricter monitoring of AI risks. 🩺 AI evaluation in healthcare: Healthcare regulations must distinguish between medical and administrative AI applications. AI in fields like psychotherapy presents unique challenges, especially concerning data protection. 🤖 Organizational and human impact of AI: AI is reshaping patient care, particularly for individuals with cognitive disorders. Training clinicians to understand and interpret AI tools is essential, as is ensuring patient acceptance of these innovations. 💬 What are your thoughts on the future of AI in healthcare? Let us know in the comments below! Catch the full session replay here! 👇 https://lnkd.in/e-4jBwC8 A big thank you to all our speakers, and we look forward to seeing you at the Grand Palais - RMN (Officiel) in 2025! #AIForHealth #AIinHealthcare #DataProtection

🇫🇷 How can the European Health Data Space (EHDS) be made an asset for France? Our White Paper is here! (In French) At the AI for Health 2024 Summit, experts came together for an engaging workshop on the EHDS! 🎤 3 Workshop Objectives - Building a shared understanding of the EHDS. - Identifying priority actions to ensure its success in France: trust, inclusive governance, and mobilizing stakeholders. - Developing a strategy to educate and engage citizens, healthcare professionals, researchers, and policymakers, emphasizing its benefits while addressing concerns. 🎯 3 Priority Actions: - Build a solid governance framework: Include trusted third parties, such as patient associations, in strategic discussions to ensure transparency and raise awareness among all stakeholders. 🤝 - Adopt a collaborative, disease-specific approach: Mobilize stakeholders around specific diseases to demonstrate the value of shared data and the effectiveness of targeted collaborations. 🌐 - Create transparency portals: Empower citizens to track the use of their data and identify data holders, reinforcing trust through transparency. 🔍 💡 3 Pillars of the Acculturation Strategy: - Communicate clearly: Simplify the benefits for citizens and reassure them about data security. 🛡️ - Tailor the messaging: Use social media to run awareness campaigns and illustrate positive impacts with concrete use cases. 📲 - Engage citizens: Diversify perspectives by establishing citizen committees and explaining key concepts such as public interest. 🌍 🙏 A Big Thank You to our Amazing Participants for their insights and their reviews of the document’s versions : Cédric COLLIN (IQVIA France), Aline Conchon, PhD (Délégation au Numérique en Santé (DNS), Sandra Courbier (Takeda France), Manon de FALLOIS (CNIL), Jérôme Fabiano (EIT Health), Clotilde Genon (ELLyE - Ensemble Leucémie Lymphomes Espoir), Julien GUERIN (Institut Curie), Lucas Guichard,  Hanauer Marc (Orphanet), Adrien Huyghues (Johnson & Johnson Innovative Medicine France), Léna Miquel (Délégation au Numérique en Santé (DNS), Cécile Théard-Jallu (De Gaulle Fleurance), Emilie PASSEMARD and Aymeric Perchant (Délégation au Numérique en Santé (DNS). We can’t wait for the next AI for Health Summit and the follow-up of these discussions! This work is only a glance at all the work and potential yet to come  ✨ Nota bene: This white paper shall not commit the institutions to which the individuals participating in this workshop are affiliated. #AIforHealth #Workshop

▶️💡 How is AI Transforming Healthcare? Catch Up on the Highlights from AI for Health Summit 2024 as We Start the New Year! We were thrilled to host an impactful session at the AI for Health Summit 2024 on November 21st at STATION F! 🔑 Experts explored how streamlining AI infrastructure is transforming healthcare during the session. A huge thank you to our amazing speakers for sharing their expertise: 🎤 Yves Mahieu, EMEA Industry Principal, Healthcare & Life Sciences from our ecosystem member Pure Storage 🎤 Julien Bianchi, Chief Technical Officer at Ospi Key Takeaways from the session: 1️⃣ Simplification of AI Projects The goal: Reduce complexity with an integrated platform featuring a pre-configured data layer, compute layer, and algorithms enabling users to focus on deploying AI models faster and more efficiently. 2️⃣ AI Infrastructure & Partnerships                                                                                The platform seamlessly scales AI projects from pre-training to inference, excelling in managing large datasets for healthcare applications such as genomics and medical imaging. 3️⃣ Cloud-Based Flexibility Start small, scale big! This cloud model offers a simple, cost-effective way to manage massive data sets and run AI models, without the need for heavy upfront infrastructure investment. Thanks to all who joined us for this dynamic session! 🌍 ➡️Discover more insights and stay tuned for upcoming sessions https://lnkd.in/e-4jBwC8 #AIforHealth

📺 How Can AI and Collaboration Transform Rare Disease Diagnosis? French session On November 21st, we hosted an exciting session at STATION F, diving into how AI and collaboration are revolutionizing the diagnosis of rare diseases. This session, part of the AI for Health Summit 2024 at Station F on the Masterclass Stage, explored: 👉 "Strategic Vision for Rare Diseases: AI & Collaborative Approach Accelerating Diagnosis" Speakers & Moderator: 🔹 Prof. Anita Burgun, Associate Researcher at Institut Imagine 🔹 Thibaud Guymard, Head of Innovation, Services & Digital at Biogen 🔹 Solange Roumengous, Head of Industrial Partnerships at French National Database of Rare Diseases 🔹 Corinne Blachier Poisson, President France at Amgen 🔹 Francois Macary, Semantic Interoperability Expert at Use-and-Share 🎤 Moderator:                                                                                                                         🔹 Virginie Lasserre, External Affairs Director at Johnson & Johnson Innovative Medicine 🔍 Key Insights: Collective initiative for Rare Diseases The Strategic Industry Committee (CSF) is uniting public and private partners to develop AI-driven solutions aimed at improving rare disease diagnosis and care, with the support of an innovation-friendly ecosystem in France. Projects like AI Data and Health are leading the way. Progress in Rare Disease Diagnosis Over 3 million people in France are affected by rare diseases, often facing diagnostic delays of 2 years or more. While most are genetic, only 6 are diagnosed at birth. AI and health data hold the potential to dramatically shorten these timelines. Innovative Projects & Challenges Initiatives like the French National Database for Rare Diseases (BNDMR) are advancing data collection and analysis to speed up diagnostics. However, obstacles in data quality, availability, and interoperability between health systems still exist. 🙏 A massive thank you to all our incredible speakers for their valuable insights and expertise. We can’t wait to see you next year at the Grand Palais - RMN (Officiel), see you in 2025! 🚀 👉 Watch the full session replay here (with AI-generated subtitles!) https://lnkd.in/e-4jBwC8 #AIForHealth #RareDiseaseInnovation

🚀 How is AI revolutionizing pharmaceutical innovation? We had the privilege of diving into cutting-edge discussions on the future of pharmaceutical innovation with an exceptional panel. On November 21st, during the AI for Health Summit 2024 at STATION F. 💡 Session: Leaders' POV: Accelerating Pharmaceutical Innovation Through AI at Servier 🎤 Moderator: Paul de Balincourt, Partner, Healthcare Data & AI Transformation, Artefact 👥 Speakers: Dr. Claude Bertrand, Executive Vice President R&D, Servier Virginie Dominguez, Executive Vice President Digital, Data & IT, Servier AI is transforming the pharmaceutical industry, speeding up innovative treatments and enhancing global healthcare access. 🌍 👉 Want to watch or rewatch this session? It's right here! https://lnkd.in/e-4jBwC8 🗓️ Don’t forget the 8th edition of the AI for Health Summit at the Grand Palais - RMN (Officiel) ✨ #AIforHealth #PharmaceuticalInnovation #AI #HealthcareTransformation